| Clarence Tc Ching Villas At St Francis | |
| 2230 Liliha Street, Honolulu, Hawaii 96817 | |
| (808) 547-6000 | |
| Name | Clarence Tc Ching Villas At St Francis |
|---|---|
| Location | 2230 Liliha Street, Honolulu, Hawaii |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 119 |
| Occupancy Rate | 73.95% |
| Medicare ID (CCN) | 125064 |
| Legal Business Name | Liliha Kupuna Snf Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1164815338 |
| Organization Name | LILIHA KUPUNA SNF, LLC. |
| Doing Business As | CLARENCE T.C. CHING VILLAS AT ST. FRANCIS |
| Address | 2230 Liliha St, Honolulu, HI 96817 |
| Phone Number | 808-547-6003 |
News Archive
A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Misys PLC, a global provider of application software and services for the banking and financial industry, has announced that the National Bank of Abu Dhabi will deploy its commercial lending solution, Misys Loan IQ, for its loan operations.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
› Verified 9 days ago
| NPI Number | 1598082745 |
| Organization Name | ST. FRANCIS HOSPITAL - LILIHA |
| Address | 2230 Liliha St, Honolulu, HI 96817 |
| Phone Number | 808-547-8001 |
News Archive
A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Misys PLC, a global provider of application software and services for the banking and financial industry, has announced that the National Bank of Abu Dhabi will deploy its commercial lending solution, Misys Loan IQ, for its loan operations.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
› Verified 9 days ago
| NPI Number | 1780756205 |
| Organization Name | HAWAII MEDICAL CENTER EAST |
| Address | 2230 Liliha St, Honolulu, HI 96817 |
| Phone Number | 808-547-6011 |
News Archive
A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Misys PLC, a global provider of application software and services for the banking and financial industry, has announced that the National Bank of Abu Dhabi will deploy its commercial lending solution, Misys Loan IQ, for its loan operations.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
› Verified 9 days ago
| NPI Number | 1922102961 |
| Organization Name | ST. FRANCIS MEDICAL CENTER |
| Address | 2230 Liliha St, Honolulu, HI 96817 |
| Phone Number | 808-547-6000 |
News Archive
A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Misys PLC, a global provider of application software and services for the banking and financial industry, has announced that the National Bank of Abu Dhabi will deploy its commercial lending solution, Misys Loan IQ, for its loan operations.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Misys PLC, a global provider of application software and services for the banking and financial industry, has announced that the National Bank of Abu Dhabi will deploy its commercial lending solution, Misys Loan IQ, for its loan operations.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $15172 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|